Cargando…
IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway
Background: N6-methyladenosine (m(6)A) is the most abundant modification in eukaryotic mRNA. However, its role in non-small cell lung cancer (NSCLC) has not been completely elucidated. Objective: To explore whether methyltransferase like 3 (METTL3) in cancer associated fibroblasts (CAFs) affects the...
Autores principales: | Xu, Li, Li, Kang, Li, Jia, Xu, Fang, Liang, Shuzhi, Kong, Yi, Chen, Bolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595399/ https://www.ncbi.nlm.nih.gov/pubmed/37871286 http://dx.doi.org/10.1080/15592294.2023.2265625 |
Ejemplares similares
-
OPN Promotes Cell Proliferation and Invasion through NF-κB in Human Esophageal Squamous Cell Carcinoma
por: Chen, Bolin, et al.
Publicado: (2022) -
Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway
por: Zheng, Yang, et al.
Publicado: (2022) -
METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-κB Signaling Pathway
por: Wang, Jinghua, et al.
Publicado: (2019) -
METTL3 Promotes Activation and Inflammation of FLSs Through the NF-κB Signaling Pathway in Rheumatoid Arthritis
por: Shi, Wen, et al.
Publicado: (2021) -
Antibiotic
Chlortetracycline Causes Transgenerational
Immunosuppression via NF-κB
por: Qiu, Wenhui, et al.
Publicado: (2022)